5:00pm: The Indian rupee closed at 63.51 against the US dollar, up 0.15% from its previous close of 63.61. 3:30pm: The S&P BSE Sensex closes... ...http://www.livemint.com/Money/PsVf4MwWtqSMURXyXGURKK/Live-markets-Sensex-rises-45-points-Nestle-gains-3.html
Cadila Healthcare rose 1.29% to Rs 1,820 at 15:15 IST on BSE after the company said the Zydus group has received the market authorisation from the... ...http://www.business-standard.com/article/news-cm/cadila-healthcare-gains-after-receiving-market-authorisation-from-usfda-for-a-medicine-115070100556_1.html
Shares of Cadila Healthcare climbed 3 percent intraday Wednesday after the Zydus group allowed to market its strong pain killer drug in the US.... ...http://www.moneycontrol.com/news/buzzing-stocks/cadila-health3-zydus-to-market-pain-killer-drugus_1741241.html
At a time when the biosimilars market in India is expected to clock a 30 per cent growth rate between 2014 to 2018, pharma companies in Gujarat are... ...http://smartinvestor.business-standard.com/market/Compnews-320384-Compnewsdet-Biosmilars_is_the_new_focus_of_Gujarat_pharma_companies.htm
/PRNewswire/ -- Treating diabetes - benefit your influence by finding new R&D trends and sales prospects Discover the future of... ...http://in.advfn.com/p.php?pid=nmona&article=67435066
The company was formed way back in...